We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$875M
AUM Growth
+$115M
Cap. Flow
+$150M
Cap. Flow %
17.19%
Top 10 Hldgs %
75.39%
Holding
137
New
24
Increased
29
Reduced
45
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 10.64%
2 Energy 2.53%
3 Financials 0.6%
4 Technology 0.58%
5 Industrials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSAT icon
26
Telesat
TSAT
$554M
$3.73M 0.43%
260,781
+100,000
+62% +$1.36M
AMGN icon
27
Amgen
AMGN
$198B
$3.64M 0.42%
13,539
+12,170
+889% +$3.04M
REGN icon
28
Regeneron Pharmaceuticals
REGN
$70.9B
$3.54M 0.4%
4,302
+583
+16% +$458K
CRNX icon
29
Crinetics Pharmaceuticals
CRNX
$8.88B
$3.42M 0.39%
+115,000
New +$2.37M
BSX icon
30
Boston Scientific
BSX
$65.4B
$3.23M 0.37%
61,116
+49,304
+417% +$2.59M
SNY icon
31
Sanofi
SNY
$107B
$3.18M 0.36%
59,358
-21,455
-27% -$1.14M
AKRO
32
DELISTED
Akero Therapeutics
AKRO
$3.02M 0.35%
59,777
LONA
33
LeonaBio Inc
LONA
$67.8M
$3.02M 0.34%
149,279
TCRX icon
34
TScan Therapeutics
TCRX
$59.8M
$2.68M 0.31%
1,046,916
LLY icon
35
Eli Lilly
LLY
$1.05T
$2.64M 0.3%
4,915
-1,274
-21% -$656K
CI icon
36
Cigna
CI
$74.5B
$2.61M 0.3%
9,107
+2,464
+37% +$703K
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$123B
$2.58M 0.3%
7,425
-66
-0.9% -$23.1K
REPL icon
38
Replimune Group
REPL
$859M
$2.57M 0.29%
150,000
ABBV icon
39
AbbVie
ABBV
$450B
$2.55M 0.29%
17,122
+4,308
+34% +$632K
FULC icon
40
Fulcrum Therapeutics
FULC
$243M
$2.53M 0.29%
570,519
-125,777
-18% -$550K
JNJ icon
41
Johnson & Johnson
JNJ
$609B
$2.52M 0.29%
16,165
-7,598
-32% -$1.25M
SAGE
42
DELISTED
Sage Therapeutics
SAGE
$2.47M 0.28%
120,030
+70,000
+140% +$2.02M
PHAT icon
43
Phathom Pharmaceuticals
PHAT
$873M
$2.47M 0.28%
237,935
UNH icon
44
UnitedHealth
UNH
$387B
$2.41M 0.28%
4,785
+3,788
+380% +$1.86M
MDT icon
45
Medtronic
MDT
$106B
$2.31M 0.26%
29,466
-18,053
-38% -$1.51M
HARD icon
46
Simplify Commodities Strategy No K-1 ETF
HARD
$82M
$2.24M 0.26%
88,056
-43,297
-33% -$1.1M
MIRM icon
47
Mirum Pharmaceuticals
MIRM
$7.25B
$2.21M 0.25%
70,000
ISRG icon
48
Intuitive Surgical
ISRG
$122B
$2.17M 0.25%
7,421
+1,308
+21% +$408K
DAWN
49
DELISTED
Day One Biopharmaceuticals
DAWN
$2.15M 0.25%
+175,018
New +$2.28M
IBDP
50
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
0

Similar funds

Simplify Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Simplify Asset Management held 137 positions worth $875M, up 15% from $760M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Simplify Asset Management deployed $150M of net new capital in Q3 2023, opening 24 new positions and adding to 29 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 49,900 shares worth $4.43M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $24.1M trimmed.

  • Simplify Asset Management's largest Q3 2023 buy was iShares 20+ Year Treasury Bond ETF: 49,900 shares worth $4.43M.
  • Simplify Asset Management added most to Simplify Aggregate Bond ETF in Q3 2023, an estimated $52.7M increase.
  • Simplify Asset Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $24.1M.
  • Simplify Asset Management fully exited Plains All American Pipeline in Q3 2023, selling an estimated $9.16M.
  • Simplify Asset Management's ten largest holdings make up 75% of its $875M portfolio in Q3 2023.
  • Simplify Asset Management opened 24 new positions and closed 15 in Q3 2023.
  • Simplify Asset Management's portfolio value rose 15% quarter-over-quarter to $875M.

Based on Simplify Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.